Form 4 Tracker
Jeffrey G. Lamothe

Director, President and CEO · 1 filing · Latest: Aug 6, 2026

Aptevo Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
APVO
Jeffrey G. LamotheDirector, President and CEOAug 6, 2026
Option Exercise
961961